Why your body composition matters more than your weight

Two men step on a scale. Both weigh 185 pounds. Both are 5’10”. By BMI, they are identical. By every measure that actually predicts disease, disability, and early death, they could not be more different.

Person A carries 145 pounds of lean mass and 3 pounds (1.4 kg) of visceral adipose tissue, the fat packed around your organs. Person B carries 128 pounds of lean mass and 9 pounds (4.1 kg) of visceral adipose tissue. The composition is night and day, and so is the underlying risk profile.

A bathroom scale can’t see any of that. A DEXA scan, which takes about ten minutes, can.

The metric that actually matters: ASMI

At Protocol, we don’t organize our Muscle & Body Composition protocol around weight loss. We organize it around a metric called ASMI (Appendicular Skeletal Muscle Mass Index), measured in kg/m².

ASMI takes the lean mass in your arms and legs (appendicular lean mass, used as a proxy for skeletal muscle on DEXA) and divides it by your height squared. It tells you how much functional muscle you carry relative to your frame.

Why arms and legs specifically? Because appendicular muscle is what keeps you upright, mobile, and metabolically healthy. It’s the muscle that helps prevent falls at 75 (alongside balance, vision, and a meds review) and clears glucose from your bloodstream at 45. Trunk muscle matters too, but limb muscle is where the clinical thresholds are best validated.

ASMI is one of the metrics that actually shows up in the mortality literature. Body weight, on its own, mostly doesn’t.

What a DEXA scan actually shows you

DEXA (Dual-energy X-ray Absorptiometry) uses two low-dose X-ray beams to differentiate between three tissue types: lean mass, fat mass, and bone mineral content. It’s the most accurate tool available for body composition assessment.

A single DEXA scan gives you:

• Lean mass by region (arms, legs, trunk, total): this is where ASMI comes from.
• Fat mass by region: subcutaneous (under the skin) and, more importantly, visceral adipose tissue (VAT) around your organs.
• Bone mineral density (BMD): relevant for osteoporosis screening and fracture risk.
• Limb asymmetry: left vs. right lean mass differences that flag injury risk or compensation patterns.
• Android/gynoid ratio: the distribution of fat between your midsection and hips/thighs. A high ratio correlates with metabolic syndrome independent of total body fat.

None of this information exists on a bathroom scale.

The two-person problem

Back to our two 185-pound people.

Person A: ASMI 8.4 kg/m², VAT 3 lbs, android/gynoid ratio 0.85, BMD T-score -0.3 (normal). Above-average muscle mass, moderate-to-low visceral fat, healthy fat distribution, normal bone density. On the lab side, you’d expect metabolic blood work to be clean and ten-year cardiovascular risk on standard models (ASCVD, etc.) to track low — though that needs to be confirmed with actual labs.

Person B: ASMI 6.2 kg/m², VAT 9 lbs, android/gynoid ratio 1.35, BMD T-score -1.8 (osteopenic range). Low muscle mass for their frame, three times the visceral fat, centralized fat distribution, early bone loss. On the lab side, you’d expect fasting insulin to track higher and inflammatory markers to be elevated, with ten-year cardiovascular risk on the same models substantially higher — again, those need direct measurement to confirm.

Identical on weight and BMI; not remotely comparable as clinical pictures. A cardiologist or endocrinologist would manage these two patients on different timelines.

The body-composition-versus-weight question isn’t a semantic one. It changes what a doctor would actually do.

What about smart scales?

Bioelectrical impedance analysis (BIA) is the technology inside smart scales and body composition scales. It sends a small electrical current through your body and estimates fat mass based on how quickly the signal travels (lean tissue conducts better than fat tissue).

BIA has a role, but it’s narrow: daily trends only.

A single reading from a consumer smart scale can be off by 5-8 percentage points of body fat depending on hydration, meal timing, exercise, and even skin temperature. That error margin is large enough to make Person A look like Person B on a bad day.

What BIA does well is track relative changes over weeks and months. If your BIA body fat percentage drops steadily from March to June, that trend is real even if the absolute number isn’t precise. Use it for trend tracking. Do not interpret single readings as ground truth.

A reasonable setup is one DEXA a year for the truth, and a smart scale on the bathroom floor for the months in between.

Sarcopenia screening: why this matters after 50

Sarcopenia (age-related loss of muscle mass and function) is one of the most underdiagnosed conditions in medicine. It predicts falls, fractures, hospitalization, loss of independence, and all-cause mortality. And it starts earlier than most people think.

The European Working Group on Sarcopenia in Older People published its 2019 revised screening algorithm (EWGSOP2):

1. Probable sarcopenia: grip strength below 27 kg for men or 16 kg for women.
2. Confirmed sarcopenia: DEXA ASMI below 7.0 kg/m² for men or 5.5 kg/m² for women.
3. Severe sarcopenia: gait speed below 0.8 m/s (takes more than 5 seconds to walk 4 meters at normal pace).

Grip strength is the screening gate. It takes 30 seconds to measure with a hand dynamometer. If grip is low, DEXA confirms whether muscle mass is actually depleted or whether the weakness is neuromuscular. If both grip and DEXA are low and walking speed is slow, sarcopenia is severe.

The reason this matters: in the early stages, sarcopenia responds well to resistance training and adequate protein. Once it progresses to severe, reversal becomes much harder. The whole point of the screening algorithm is to catch people while they’re still in “probable” territory, when intervention still moves the needle.

Before 50: low muscle mass for age

You don’t need to be over 50 for muscle mass to matter. For adults under 50, Protocol uses age-matched percentiles rather than the EWGSOP2 thresholds (which were developed for older adults).

The benchmark: ASMI below the 25th percentile for your age and sex = “low muscle mass for age.”

It’s a flag, not a diagnosis. Your muscle reserves are in the bottom quarter of people your age, and on the current trajectory you’re heading toward sarcopenia decades earlier than necessary.

The intervention is the same: structured resistance training (Protocol 4) and protein intake calibrated to your age and activity level.

The free proxy you can measure monthly

DEXA scans are done every 12 months. Between scans, waist circumference is a useful proxy for visceral adipose tissue.

Measure at the navel, not the narrowest point of your waist. Standing, after a normal exhale.

Thresholds: above 40 inches for men or 35 inches for women correlates with elevated VAT and metabolic risk. But the trend matters more than the absolute number. If waist circumference is dropping month over month while body weight stays flat, you are likely losing visceral fat and gaining lean mass. That’s exactly the trade your body needs to make.

How body composition connects to everything else

Body composition doesn’t exist in isolation. It connects directly to other systems Protocol tracks.

On the training side, the DEXA scan directly shapes your resistance prescription (Protocol 4). Low ASMI means hypertrophy-focused programming. High VAT with adequate lean mass means a different emphasis. One program covers body composition, cardiovascular fitness, and mobility; you don’t need three separate ones.

Insulin sensitivity is the next system downstream (Protocol 3). Skeletal muscle is the primary glucose disposal organ in the body, so more lean mass means more capacity to clear glucose after a meal. Two people can eat the same meal and see very different continuous glucose monitor curves. Muscle mass is usually why.

Protein dosing comes out of ASMI and age, not body weight. An adult under 40 with adequate ASMI needs a different protein target than a 58-year-old at the 30th percentile, and the difference comes from age-stratified evidence rather than a guess. (More on this in The Protein Prescription.)

What to do with this information

If you have never had a DEXA scan, you don’t know your body composition. Full stop. You know your weight. You may know your BMI. You might have a rough sense from a smart scale. But you don’t have the data that actually matters: lean mass by region, VAT, bone density, asymmetry, fat distribution.

There’s an order to this. You measure first, then put the numbers in context for your age and sex, then decide what to actually change and in what sequence. Skipping the first two steps and jumping straight to “I should lose weight” is how people lose ten pounds of muscle and call it progress.

Protocol’s Muscle & Body Composition protocol handles all three steps in one place: DEXA for the baseline, clinical thresholds for the context, and a care team that turns the numbers into a training and protein plan and re-scans to confirm it’s working.

The scale isn’t the point, and never really was. The point is what the scale can’t see.

---

Ready to find out what your weight is actually made of? Book a Discovery Call to learn how Protocol’s body composition assessment works and what it would reveal for you.